4.6 Article

Receptor for advanced glycation end products (RAGE) partially mediates HMGB1-ERKs activation in clear cell renal cell carcinoma

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Pharmacology & Pharmacy

Non-histone nuclear factor HMGB1 as a therapeutic target in colorectal cancer

Hitoshi Ohmori et al.

EXPERT OPINION ON THERAPEUTIC TARGETS (2011)

Article Biochemistry & Molecular Biology

S100B Protein Stimulates Microglia Migration via RAGE-dependent Up-regulation of Chemokine Expression and Release

Roberta Bianchi et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2011)

Article Biochemistry & Molecular Biology

S100B alters neuronal survival and dendrite extension via RAGE-mediated NF-κB signaling

Alejandro Villarreal et al.

JOURNAL OF NEUROCHEMISTRY (2011)

Review Immunology

HMGB1 and RAGE in Inflammation and Cancer

Gary P. Sims et al.

ANNUAL REVIEW OF IMMUNOLOGY, VOL 28 (2010)

Article Oncology

HMGB1 attenuates anti-metastatic defence of the liver in colorectal cancer

Yi Luo et al.

EUROPEAN JOURNAL OF CANCER (2010)

Article Cell Biology

The expression of HMGB1 protein and its receptor RAGE in human malignant tumors

Nora Kostova et al.

MOLECULAR AND CELLULAR BIOCHEMISTRY (2010)

Review Urology & Nephrology

Renal Cell Carcinoma and Proteomics

Vanessa Sandim et al.

UROLOGIA INTERNATIONALIS (2010)

Article Gastroenterology & Hepatology

MK615 decreases RAGE expression and inhibits TAGE-induced proliferation in hepatocellular carcinoma cells

Yuhki Sakuraoka et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2010)

Review Cell Biology

The receptor RAGE: Bridging inflammation and cancer

Astrid Riehl et al.

CELL COMMUNICATION AND SIGNALING (2009)

Review Pathology

Management of metastatic renal cell carcinoma: current trends

Aza Mohammed et al.

EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2009)

Article Medicine, Research & Experimental

Serum high mobility group box-1 (HMGB1) is closely associated with the clinical and pathologic features of gastric cancer

Hye Won Chung et al.

JOURNAL OF TRANSLATIONAL MEDICINE (2009)

Article Immunology

RAGE signaling sustains inflammation and promotes tumor development

Christoffer Gebhardt et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2008)

Review Medicine, Research & Experimental

The alternative NF-κB activation pathway and cancer : friend or foe?

Veronique Baud et al.

M S-MEDECINE SCIENCES (2008)

Article Chemistry, Multidisciplinary

Growth suppression and radiosensitivity increase by HMGB1 in breast cancer

Yang Jiao et al.

ACTA PHARMACOLOGICA SINICA (2007)

Review Medicine, Research & Experimental

RAGE and RAGE ligands in cancer

Craig D. Logsdon et al.

CURRENT MOLECULAR MEDICINE (2007)

Article Oncology

Effect of cromolyn on S100P interactions with RAGE and pancreatic cancer growth and invasion in mouse models

Thiruvengadam Arumugam et al.

JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)

Review Biochemistry & Molecular Biology

Introduction to NF-κB:: players, pathways, perspectives

T. D. Gilmore

ONCOGENE (2006)

Article Medicine, General & Internal

Prognostic significance of morphologic parameters in renal cell carcinoma

F Erdogan et al.

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2004)

Article Oncology

High-mobility group protein 1(Y): Metastasis-associated or metastasis-inducing?

A Evans et al.

JOURNAL OF SURGICAL ONCOLOGY (2004)

Article Oncology

TNM residual tumor classification revisited

C Wittekind et al.

CANCER (2002)

Article Multidisciplinary Sciences

Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases

A Taguchi et al.

NATURE (2000)